Intranasal neostigmine therapy of botulinum toxin (BTX) treatment dysphagia.
Marchini
C
C
D000281:Administration, Intranasal; D001905:Botulinum Toxins / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage*; D010277:Parasympathomimetics / Q000008:administration & dosage*
D010277:Parasympathomimetics; D009388:Neostigmine; D001905:Botulinum Toxins